LoTempio Maria M, Wang Kevin H, Sadeghi Ahmed, Delacure Mark D, Juillard Guy F, Wang Marilene B
Division of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1624, USA.
Otolaryngol Head Neck Surg. 2005 Jun;132(6):948-53. doi: 10.1016/j.otohns.2004.12.014.
To evaluate quality of life issues in patients with laryngeal cancer after treatment with either chemoradiation or total laryngectomy and radiation therapy.
Forty-nine patients with a history of stage II-IV laryngeal squamous cell carcinoma treated primarily with either chemoradiation or by total laryngectomy with postoperative radiation completed the University of Washington Quality of Life instrument, version 4. Patients were identified on a volunteer basis in an academic university head and neck clinic setting. Each patient completed the above instrument, and statistical analysis was performed by Wilcoxon and chi 2 tests.
Instruments were completed by all 49 patients: 15 patients who underwent primary chemoradiation and 34 patients who underwent a total laryngectomy followed by radiation. Domains reported in both treatment groups without significant differences were appearance, activity, recreation, moods, taste, saliva, anxiety, and general questions. However, there were significant differences between the 2 groups in the domains of pain, swallowing, chewing, speech, and shoulder function. The laryngectomy patients reported greater impairment of speech (P = 0.001), and shoulder function (P = 0.018), whereas the chemoradiation patients suffered from greater pain, difficulty swallowing (P = 0.061), and problems chewing (P = 0.027).
Most patients with laryngeal cancer, whether treated primarily with chemoradiation or total laryngectomy, reported excellent functional outcomes and health-related quality of life. Pain, swallowing, chewing, saliva, and shoulder function were recorded as significant factors affecting their daily quality of life.
评估喉癌患者在接受放化疗或全喉切除术加放射治疗后的生活质量问题。
49例曾接受过II-IV期喉鳞状细胞癌治疗的患者,主要接受了放化疗或全喉切除术后放疗,他们完成了华盛顿大学生活质量量表第4版。这些患者是在一所学术性大学的头颈诊所中通过自愿报名确定的。每位患者完成上述量表,采用Wilcoxon检验和卡方检验进行统计分析。
49例患者均完成了量表:15例接受了原发放化疗,34例接受了全喉切除术后放疗。两个治疗组在外观、活动、娱乐、情绪、味觉、唾液、焦虑和一般问题等方面的报告没有显著差异。然而,两组在疼痛、吞咽、咀嚼、言语和肩部功能等方面存在显著差异。接受全喉切除术的患者言语功能(P = 0.001)和肩部功能(P = 0.018)受损更严重,而接受放化疗的患者疼痛更严重,吞咽困难(P = 0.061),咀嚼问题(P = 0.027)更严重。
大多数喉癌患者,无论最初接受的是放化疗还是全喉切除术,其功能结局和与健康相关的生活质量都良好。疼痛、吞咽、咀嚼、唾液和肩部功能被记录为影响其日常生活质量的重要因素。